(CAG) ConAgra Foods - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US2058871029
Frozen Meals, Shelf-Stable Entrees, Snacks, Baking Mixes, Whipped Toppings
Dividends
| Dividend Yield | 7.89% |
| Yield on Cost 5y | 4.92% |
| Yield CAGR 5y | 11.25% |
| Payout Consistency | 94.2% |
| Payout Ratio | 66.4% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 25.6% |
| Value at Risk 5%th | 41.1% |
| Relative Tail Risk | -2.25% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.55 |
| Alpha | -37.03 |
| CAGR/Max DD | -0.35 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.344 |
| Beta | 0.096 |
| Beta Downside | 0.006 |
| Drawdowns 3y | |
|---|---|
| Max DD | 52.41% |
| Mean DD | 26.60% |
| Median DD | 26.23% |
Description: CAG ConAgra Foods November 04, 2025
Conagra Brands, Inc. (NYSE:CAG) is a U.S.–based consumer packaged goods company that sells a broad portfolio of shelf-stable, refrigerated, and frozen foods across four segments: Grocery & Snacks, Refrigerated & Frozen, International, and Foodservice. Its brands-including Birds Eye, Marie Callender’s, Duncan Hines, Healthy Choice, Slim Jim, Reddi-Wip, Angies, and BOOMCHICKAPOP-are distributed through grocery retailers, club stores, e-commerce platforms, and foodservice outlets, with the International segment extending these offerings outside the United States.
Key performance indicators to watch include the 12-month trailing same-store sales growth in the Grocery & Snacks segment (historically 2-4% YoY) and the contribution margin expansion from the Refrigerated & Frozen segment, which has benefited from higher pricing power amid rising commodity costs. Macro drivers such as U.S. consumer discretionary spending trends, inflation-adjusted food price indices, and the shift toward “convenient at-home” meals continue to shape demand, while the ongoing supply-chain bottlenecks in cold-storage logistics present both risk and upside for margin improvement.
For a deeper, data-driven assessment of Conagra’s valuation and risk profile, you may find the analytics on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (850.1m TTM) > 0 and > 6% of Revenue (6% = 687.0m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -1.50pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 1.84% (prev -1.93%; Δ 3.77pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 1.54b > Net Income 850.1m (YES >=105%, WARN >=100%) |
| Net Debt (7.58b) to EBITDA (1.91b) ratio: 3.96 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.06 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (479.6m) change vs 12m ago -0.15% (target <= -2.0% for YES) |
| Gross Margin 25.37% (prev 27.21%; Δ -1.84pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 53.99% (prev 56.20%; Δ -2.22pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.74 (EBITDA TTM 1.91b / Interest Expense TTM 407.6m) >= 6 (WARN >= 3) |
Altman Z'' 2.42
| (A) 0.01 = (Total Current Assets 3.84b - Total Current Liabilities 3.63b) / Total Assets 21.17b |
| (B) 0.32 = Retained Earnings (Balance) 6.76b / Total Assets 21.17b |
| (C) 0.07 = EBIT TTM 1.53b / Avg Total Assets 21.21b |
| (D) 0.79 = Book Value of Equity 9.69b / Total Liabilities 12.26b |
| Total Rating: 2.42 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 50.78
| 1. Piotroski 3.0pt |
| 2. FCF Yield 7.25% |
| 3. FCF Margin 9.96% |
| 4. Debt/Equity 0.93 |
| 5. Debt/Ebitda 3.96 |
| 6. ROIC - WACC (= 1.59)% |
| 7. RoE 9.60% |
| 8. Rev. Trend -42.64% |
| 9. EPS Trend -50.26% |
What is the price of CAG shares?
As of December 14, 2025, the stock is trading at USD 17.75 with a total of 7,069,563 shares traded.
Over the past week, the price has changed by +4.11%, over one month by +2.36%, over three months by -5.50% and over the past year by -32.41%.
Over the past week, the price has changed by +4.11%, over one month by +2.36%, over three months by -5.50% and over the past year by -32.41%.
Is CAG a buy, sell or hold?
ConAgra Foods has received a consensus analysts rating of 3.16.
Therefor, it is recommend to hold CAG.
- Strong Buy: 0
- Buy: 3
- Hold: 16
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CAG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 20.2 | 13.9% |
| Analysts Target Price | 20.2 | 13.9% |
| ValueRay Target Price | 16.6 | -6.7% |
CAG Fundamental Data Overview December 09, 2025
Market Cap USD = 8.16b (8.16b USD * 1.0 USD.USD)
P/E Trailing = 9.6328
P/E Forward = 10.8696
P/S = 0.7123
P/B = 0.9148
P/EG = 12.0743
Beta = -0.016
Revenue TTM = 11.45b USD
EBIT TTM = 1.53b USD
EBITDA TTM = 1.91b USD
Long Term Debt = 7.22b USD (from longTermDebt, last quarter)
Short Term Debt = 1.06b USD (from shortTermDebt, last quarter)
Debt = 8.28b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.58b USD (from netDebt column, last quarter)
Enterprise Value = 15.74b USD (8.16b + Debt 8.28b - CCE 698.1m)
Interest Coverage Ratio = 3.74 (Ebit TTM 1.53b / Interest Expense TTM 407.6m)
FCF Yield = 7.25% (FCF TTM 1.14b / Enterprise Value 15.74b)
FCF Margin = 9.96% (FCF TTM 1.14b / Revenue TTM 11.45b)
Net Margin = 7.42% (Net Income TTM 850.1m / Revenue TTM 11.45b)
Gross Margin = 25.37% ((Revenue TTM 11.45b - Cost of Revenue TTM 8.55b) / Revenue TTM)
Gross Margin QoQ = 24.33% (prev 25.42%)
Tobins Q-Ratio = 0.74 (Enterprise Value 15.74b / Total Assets 21.17b)
Interest Expense / Debt = 1.16% (Interest Expense 95.7m / Debt 8.28b)
Taxrate = 43.10% (124.6m / 289.1m)
NOPAT = 868.4m (EBIT 1.53b * (1 - 43.10%))
Current Ratio = 1.06 (Total Current Assets 3.84b / Total Current Liabilities 3.63b)
Debt / Equity = 0.93 (Debt 8.28b / totalStockholderEquity, last quarter 8.92b)
Debt / EBITDA = 3.96 (Net Debt 7.58b / EBITDA 1.91b)
Debt / FCF = 6.65 (Net Debt 7.58b / FCF TTM 1.14b)
Total Stockholder Equity = 8.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.02% (Net Income 850.1m / Total Assets 21.17b)
RoE = 9.60% (Net Income TTM 850.1m / Total Stockholder Equity 8.86b)
RoCE = 9.49% (EBIT 1.53b / Capital Employed (Equity 8.86b + L.T.Debt 7.22b))
RoIC = 5.08% (NOPAT 868.4m / Invested Capital 17.10b)
WACC = 3.49% (E(8.16b)/V(16.44b) * Re(6.37%) + D(8.28b)/V(16.44b) * Rd(1.16%) * (1-Tc(0.43)))
Discount Rate = 6.37% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.02%
[DCF Debug] Terminal Value 79.86% ; FCFE base≈1.27b ; Y1≈1.42b ; Y5≈1.90b
Fair Price DCF = 68.80 (DCF Value 32.91b / Shares Outstanding 478.4m; 5y FCF grow 14.02% → 3.0% )
EPS Correlation: -50.26 | EPS CAGR: -15.52% | SUE: 0.0 | # QB: 0
Revenue Correlation: -42.64 | Revenue CAGR: -3.92% | SUE: 0.36 | # QB: 0
EPS next Quarter (2026-02-28): EPS=0.44 | Chg30d=+0.000 | Revisions Net=-2 | Analysts=2
EPS current Year (2026-05-31): EPS=1.82 | Chg30d=+0.090 | Revisions Net=-1 | Growth EPS=-24.1% | Growth Revenue=-3.3%
EPS next Year (2027-05-31): EPS=1.86 | Chg30d=-0.010 | Revisions Net=-3 | Growth EPS=+6.1% | Growth Revenue=-0.8%
P/E Trailing = 9.6328
P/E Forward = 10.8696
P/S = 0.7123
P/B = 0.9148
P/EG = 12.0743
Beta = -0.016
Revenue TTM = 11.45b USD
EBIT TTM = 1.53b USD
EBITDA TTM = 1.91b USD
Long Term Debt = 7.22b USD (from longTermDebt, last quarter)
Short Term Debt = 1.06b USD (from shortTermDebt, last quarter)
Debt = 8.28b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.58b USD (from netDebt column, last quarter)
Enterprise Value = 15.74b USD (8.16b + Debt 8.28b - CCE 698.1m)
Interest Coverage Ratio = 3.74 (Ebit TTM 1.53b / Interest Expense TTM 407.6m)
FCF Yield = 7.25% (FCF TTM 1.14b / Enterprise Value 15.74b)
FCF Margin = 9.96% (FCF TTM 1.14b / Revenue TTM 11.45b)
Net Margin = 7.42% (Net Income TTM 850.1m / Revenue TTM 11.45b)
Gross Margin = 25.37% ((Revenue TTM 11.45b - Cost of Revenue TTM 8.55b) / Revenue TTM)
Gross Margin QoQ = 24.33% (prev 25.42%)
Tobins Q-Ratio = 0.74 (Enterprise Value 15.74b / Total Assets 21.17b)
Interest Expense / Debt = 1.16% (Interest Expense 95.7m / Debt 8.28b)
Taxrate = 43.10% (124.6m / 289.1m)
NOPAT = 868.4m (EBIT 1.53b * (1 - 43.10%))
Current Ratio = 1.06 (Total Current Assets 3.84b / Total Current Liabilities 3.63b)
Debt / Equity = 0.93 (Debt 8.28b / totalStockholderEquity, last quarter 8.92b)
Debt / EBITDA = 3.96 (Net Debt 7.58b / EBITDA 1.91b)
Debt / FCF = 6.65 (Net Debt 7.58b / FCF TTM 1.14b)
Total Stockholder Equity = 8.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.02% (Net Income 850.1m / Total Assets 21.17b)
RoE = 9.60% (Net Income TTM 850.1m / Total Stockholder Equity 8.86b)
RoCE = 9.49% (EBIT 1.53b / Capital Employed (Equity 8.86b + L.T.Debt 7.22b))
RoIC = 5.08% (NOPAT 868.4m / Invested Capital 17.10b)
WACC = 3.49% (E(8.16b)/V(16.44b) * Re(6.37%) + D(8.28b)/V(16.44b) * Rd(1.16%) * (1-Tc(0.43)))
Discount Rate = 6.37% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.02%
[DCF Debug] Terminal Value 79.86% ; FCFE base≈1.27b ; Y1≈1.42b ; Y5≈1.90b
Fair Price DCF = 68.80 (DCF Value 32.91b / Shares Outstanding 478.4m; 5y FCF grow 14.02% → 3.0% )
EPS Correlation: -50.26 | EPS CAGR: -15.52% | SUE: 0.0 | # QB: 0
Revenue Correlation: -42.64 | Revenue CAGR: -3.92% | SUE: 0.36 | # QB: 0
EPS next Quarter (2026-02-28): EPS=0.44 | Chg30d=+0.000 | Revisions Net=-2 | Analysts=2
EPS current Year (2026-05-31): EPS=1.82 | Chg30d=+0.090 | Revisions Net=-1 | Growth EPS=-24.1% | Growth Revenue=-3.3%
EPS next Year (2027-05-31): EPS=1.86 | Chg30d=-0.010 | Revisions Net=-3 | Growth EPS=+6.1% | Growth Revenue=-0.8%
Additional Sources for CAG Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle